Key share data

Share class Registered shares (no par value)
Transparency level Prime Standard
ISIN DE0006046113
WKN 604611
Ticker symbol B8F
Total shares issued 44,632,674
Freefloat ~ 65 %
Stock exchanges Xetra, all other German stock exchanges
Designated sponsors Lang & Schwarz Broker
First day of trading 30 October 2006

Nasdaq Stock Exchange

Ticker Symbol BFRA
Securities traded ADS (each representing two common shares)
Market segment Nasdaq Capital Market
First day of trading 24 February 2018


IPO Prospectus

shareholder structure

Voting rights (status July 2019)  
*in accordance to the latest mandatory publications of the sharholder  
Shareholder with stakes of more than 3% Share of voting rights*
Maruho Co. Ltd., Japan (Maruho Deutschland GmbH) 20.1%
Wilhelm K. T. Zours (Deutsche Balaton AG Gruppe) 25.97%

Analyst coverage

Biofrontera is followed by the research analysts listed below.

Please note that any opinions, estimates, or forecasts regarding Biofrontera’s performance made by these analysts are theirs alone and do not represent opinions, forecasts, or predictions of the company or its management. Biofrontera does not in any way, directly or indirectly endorse or concur with, such information, conclusions, or recommendations of these analysts.

Biofrontera does not provide US- analyst reports. Please contact the research analyst directly to obtain a copy.

Financial Institution Analyst
Benchmark Company, LLC Bruce D. Jackson
Lake Street Capital Markets Thomas Flaten
Dawson James Robert Wasserman
sc-consult GmbH Dipl. Kfm. Holger Steffen